Table 3 Potential novel classes of bronchodilators
  • Selective phosphodiesterase inhibitors

  • Potassium channel openers

  • Vasoactive intestinal peptide analogues

  • Rho kinase inhibitors

  • Brain natriuretic peptide and analogues

  • Nitric oxide donors

  • E-prostanoid receptor 4 agonists

  • Bitter taste receptor agonists